Diseases & Disorders
(G018)
IRS Verified
DX Registered
990 on File
AUTISM SOCIETY OF IOWA
Financial strength (30%)
71/100
Reliability (20%)
50/100
Effectiveness (25%)
53/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$102K
Total Revenue
$96K
Total Expenses
$127K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
56.4%
Fundraising Efficiency
45.8%
Operating Reserve
15.95x
Liability-to-Asset
0.0%
Revenue Diversification
60.9%
Compared with Peers
FY 2025
Compared with 783 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
56.4% | 79.3% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
45.8% | 37.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.0 mo | 20.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
60.9% | 99.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
19.9% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-0.9% | -2.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
6.8% | 12.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $102K | $96K | $127K | 56.4% | — |
| 2024 | $85K | $96K | $120K | 55.3% | — |
| 2023 | $76K | $109K | $105K | 54.6% | — |
| 2022 | $112K | $86K | $138K | 54.2% | — |
| 2021 | $166K | $76K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.